Medicis rated 'Strong Sell' on weak dermatology sales

Analysts give US-based Medicis Pharmaceutical a "Strong Sell" rating after dermatology sales disappoint

Matrix Research analysts have given US-based Medicis Pharmaceutical a "Strong Sell" rating.

Analysts say that the company's dermatology sales had risen only four per cent over the eight-quarter period ended June 2007. With a 40 per cent rise in Medicis' capital over the period, the company's return on capital has declined significantly.

In August 2007, Swedish biotechnology company Q-Med said it was eyeing a merger with Medicis.

Q-Med's CEO, Bengt Agerup, who owns 47.5 per cent of the firm, said that a union with Medicis made "industrial sense". The company had partnered with Medicis on the marketing of the Swedish firm's cosmetic filler Restylane.

No concrete merger talks were ongoing at the time, but if the valuations of the company changed, talks might be initiated, added Agerup.

17th September 2007

PME Digital Edition

Featured jobs

Senior Account Manager: Competitive Salary Offered

Editorial Manager - MedComms: DOE

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Account Director: Competitive Salary Offered

Experienced Medical Writers: Competitive Salary and Benefits

Account Manager / Senior Account Manager: 35, 000-40, 000

CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...: EXCELLENT DAY RATES AVAILABLE

Medical Writer: Salary TBC

Account Executive/ Senior Account Executive: competitive Salary Offfered

Associate Medical Director: Excellent PTO, bonus and 401k package

Principal Health Economist - North-West: Negotiable

Senior Editorial Assistant – Greater Manchester: DOE

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Account Director – Healthcare Marketing – Berks: Salary TBC

Associate Director: £75, 000-90, 000

Account Manager: Negotiable

Account Manager / Account Director: Competative

Account Manager- Healthcare Advertising: Negotiable

Business Director: Competitive Salary Offered

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Healthcare Communications Account Directors x 2: Salary TBC

Business Development Director – Health Education: excellent commission

AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls: ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...